Fidelity Investments’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$255M Sell
3,764,844
-533,329
-12% -$30.2M 0.01% 762
2025
Q4
$178M Buy
4,298,173
+432,371
+11% +$17.9M 0.01% 914
2025
Q3
$156M Buy
3,865,802
+9,541
+0.2% +$277K 0.01% 959
2025
Q2
$100M Buy
3,856,261
+1,311,163
+52% +$31.6M 0.01% 1115
2025
Q1
$62.3M Buy
2,545,098
+111,505
+5% +$3.14M ﹤0.01% 1279
2024
Q4
$69.8M Buy
2,433,593
+2,287,987
+1,571% +$78.3M ﹤0.01% 1262
2024
Q3
$5.49M Buy
145,606
+145,432
+83,582% +$5.1M ﹤0.01% 2100
2024
Q2
$5.49K Buy
174
+17
+11% +$589 ﹤0.01% 4518
2024
Q1
$6.89K Buy
+157
New +$6.41K ﹤0.01% 4405

Other funds holding CGON